BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35090253)

  • 1. [The predictive value of the CHA
    Qing P; Yang YM; Hu LT; Yu W; Xu LL; Wang N; Suo N
    Zhonghua Nei Ke Za Zhi; 2022 Feb; 61(2):177-184. PubMed ID: 35090253
    [No Abstract]   [Full Text] [Related]  

  • 2. Usefulness of the CHA
    Peng H; Sun Z; Chen H; Zhang Y; Ding X; Zhao XQ; Li H
    Am J Cardiol; 2019 Aug; 124(4):476-484. PubMed ID: 31235063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of CHADS2 and CHA2DS2-VASc scores for post-discharge outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Ma X; Shao Q; Dong L; Cheng Y; Lv S; Shen H; Liang J; Wang Z; Zhou Y
    Medicine (Baltimore); 2020 Jul; 99(30):e21321. PubMed ID: 32791726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk evaluation of new-onset atrial fibrillation complicating ST-segment elevation myocardial infarction: a comparison between GRACE and CHA
    Luo J; Dai L; Li J; Zhao J; Li Z; Qin X; Li H; Liu B; Wei Y
    Clin Interv Aging; 2018; 13():1099-1109. PubMed ID: 29922048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of CHA2DS2-VASc score combined with hs-CRP for new-onset atrial fibrillation in elderly patients with acute myocardial infarction.
    Fu Y; Pan Y; Gao Y; Yang X; Chen M
    BMC Cardiovasc Disord; 2021 Apr; 21(1):175. PubMed ID: 33849448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of CHA2DS2-VASC Score with in-Hospital Cardiovascular Adverse Events in Patients with Acute ST-Segment Elevation Myocardial Infarction.
    Fang C; Chen Z; Zhang J; Jin X; Yang M
    Int J Clin Pract; 2022; 2022():3659381. PubMed ID: 36225534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of GRACE and CHA2DS2-VASc score among patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Guo T; Xi Z; Qiu H; Wang Y; Zheng J; Dou K; Xu B; Qiao S; Yang W; Gao R
    Ann Med; 2021 Dec; 53(1):2215-2224. PubMed ID: 34791980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CHA2DS2-VASc-HS score in non-ST elevation acute coronary syndrome patients: assessment of coronary artery disease severity and complexity and comparison to other scoring systems in the prediction of in-hospital major adverse cardiovascular events.
    Taşolar H; Çetin M; Ballı M; Bayramoğlu A; Otlu YÖ; Türkmen S; Aktürk E
    Anatol J Cardiol; 2016 Oct; 16(10):742-748. PubMed ID: 27025198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incorporating uric acid into the CHA2DS2-VASc score improves the prediction of new-onset atrial fibrillation in patients with acute myocardial infarction.
    Wu X; Zhang Y; Yang X; Xu Z; Feng Y
    BMC Cardiovasc Disord; 2023 Oct; 23(1):522. PubMed ID: 37891493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of CHA2DS2-VASc score in predicting high SYNTAX score and in-hospital mortality for non-ST elevation myocardial infarction in patients without atrial fibrillation.
    Akboğa MK; Yılmaz S; Yalçın R
    Anatol J Cardiol; 2021 Nov; 25(11):789-795. PubMed ID: 34734812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CHA2DS2-VASc score is useful in predicting poor 12-month outcomes following myocardial infarction in diabetic patients without atrial fibrillation.
    Hudzik B; Szkodziński J; Hawranek M; Lekston A; Poloński L; Gąsior M
    Acta Diabetol; 2016 Oct; 53(5):807-15. PubMed ID: 27339195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of CHADS
    Pang H; Han B; Fu Q; Zong Z
    Sci Rep; 2017 Jul; 7(1):4730. PubMed ID: 28680116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation.
    Tu HT; Campbell BC; Meretoja A; Churilov L; Lees KR; Donnan GA; Davis SM
    Cerebrovasc Dis; 2013; 36(4):273-80. PubMed ID: 24135809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of CHA
    Maden O; Çakmak Karaaslan Ö; Kanal Y; Yakut İ; Yaman NM; Könte HC; Balcı KG; Selçuk MT; Selçuk H
    Herz; 2022 Oct; 47(5):456-464. PubMed ID: 34608522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Predictive Value of CHA
    Borovac JA; Kwok CS; Mohamed MO; Fischman DL; Savage M; Alraies C; Kalra A; Nolan J; Zaman A; Ahmed J; Bagur R; Mamas MA
    Cardiovasc Revasc Med; 2021 Aug; 29():61-68. PubMed ID: 32828675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel Risk Scoring System to Predict Cardiovascular Death in Patients With Acute Myocardial Infarction: CHA
    Kundi H; Kiziltunc E; Korkmaz A; Cicek G; Ornek E; Ileri M
    Clin Appl Thromb Hemost; 2018 Mar; 24(2):273-278. PubMed ID: 28627231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ATRIA score is superior to the m-CHA2DS2-Vasc score in predicting in-hospital mortality in COVID-19.
    Abacioglu OO; Yildirim A
    Rev Assoc Med Bras (1992); 2021 Mar; 67(3):443-448. PubMed ID: 34468612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Predictive Value of CHA2DS2-VASc Score on Residual Syntax Score in Patients With ST Segment Elevation Myocardial Infarction.
    Kalkan AK; Kahraman S; Avci Y; Bulut U; Gulmez R; Turkyilmaz AB; Erturk M
    Arq Bras Cardiol; 2022 Sep; 119(3):393-399. PubMed ID: 35830076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute myocardial infarction in patients with atrial fibrillation with a CHA2DS2-VASc score of 0 or 1: a nationwide cohort study.
    Chao TF; Huang YC; Liu CJ; Chen SJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chen TJ; Hsieh MH; Lip GY; Chen SA
    Heart Rhythm; 2014 Nov; 11(11):1941-7. PubMed ID: 25101483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study on the predictive ability of emergency CHADS
    Huang X; Lv H; Liu Z; Liu Y; Yang X
    J Thorac Dis; 2022 Jul; 14(7):2611-2620. PubMed ID: 35928606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.